Our data, corroborated by findings from Apostoli et al.25 and Nakles et al.26, suggest the biphasic action of PPARγ in breast cancer development, with a pro-tumorigenic role in the early phase of malignant transformation. This evidence concerns the gene PPARG and breast carcinoma.